









Mercado
/
Acciones
/
nasdaq-cor
/

Cencora Inc

COR

350.320USD

+4.320+1.25%

Cierre 12/15, 16:00（ET）Cotizaciones retrasadas 15 min

67.94BCap. mercado

43.69P/E TTM



Cencora Inc

350.320

+4.320+1.25%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Cencora Inc Compañía

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Información de Cencora Inc



Símbolo de cotizaciónCOR

Nombre de la empresaCencora Inc

Fecha de salida a bolsaMay 28, 1996

Director ejecutivoMauch (Robert P)

Número de empleados51000

Tipo de seguridadOrdinary Share

Fin del año fiscalMay 28

Dirección1 West First Avenue

CiudadCONSHOHOCKEN

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal19428

Teléfono16107277000

Sitio Webhttps://www.cencora.com/

Símbolo de cotizaciónCOR

Fecha de salida a bolsaMay 28, 1996

Director ejecutivoMauch (Robert P)

Ejecutivos de Cencora Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Elizabeth S. Campbell

Executive Vice President, Chief Legal Officer

27.24K

+112.43%

Ms. Silvana Battaglia

Chief Human Resources Officer, Executive Vice President

20.47K

+80.39%

Mr. Lon R. Greenberg

Independent Director

19.11K

-13.57%

Mr. Dennis M. Nally

Independent Director

12.63K

+0.83%

Mr. Pawan Verma

Executive Vice President, Chief Data and Information Officer

5.15K

+23.04%

Mr. Werner Baumann

Independent Director

3.13K

+3.57%

Dr. Lorence H. Kim, M.D.

Independent Director

957.00

+469.64%

Ms. Lori J. Ryerkerk

Independent Director

516.00

Ms. Lauren M. Tyler

Independent Director

Mr. Bennett S. Murphy

Senior Vice President, Investor Relations

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Elizabeth S. Campbell

Executive Vice President, Chief Legal Officer

27.24K

+112.43%

Ms. Silvana Battaglia

Chief Human Resources Officer, Executive Vice President

20.47K

+80.39%

Mr. Lon R. Greenberg

Independent Director

19.11K

-13.57%

Mr. Dennis M. Nally

Independent Director

12.63K

+0.83%

Mr. Pawan Verma

Executive Vice President, Chief Data and Information Officer

5.15K

+23.04%

Mr. Werner Baumann

Independent Director

3.13K

+3.57%

Desglose de ingresos

La empresa aún no ha revelado los datos relevantes.

La empresa aún no ha revelado los datos relevantes.

Por negocio

Por región

La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: lun., 17 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

12.02%

BlackRock Institutional Trust Company, N.A.

6.60%

State Street Investment Management (US)

4.74%

Walgreens Boots Alliance Inc

3.85%

T. Rowe Price Associates, Inc.

3.79%

Otro

69.00%

Accionistas

Proporción

The Vanguard Group, Inc.

12.02%

BlackRock Institutional Trust Company, N.A.

6.60%

State Street Investment Management (US)

4.74%

Walgreens Boots Alliance Inc

3.85%

T. Rowe Price Associates, Inc.

3.79%

Otro

69.00%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

53.44%

Investment Advisor/Hedge Fund

30.19%

Corporation

3.85%

Research Firm

3.09%

Hedge Fund

2.83%

Pension Fund

2.43%

Bank and Trust

2.23%

Sovereign Wealth Fund

1.26%

Family Office

1.17%

Participación institucional



Actualizado: lun., 8 de dic

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

2325

185.17M

94.90%

+31.68K

2025Q3

2360

185.31M

95.09%

+4.64M

2025Q2

2343

180.65M

95.85%

-533.00K

2025Q1

2278

180.99M

94.03%

-1.15M

2024Q4

2205

177.00M

96.12%

-3.08M

2024Q3

2114

179.91M

93.30%

+3.58M

2024Q2

2070

176.04M

91.35%

-1.09M

2024Q1

2048

176.18M

88.49%

-350.13K

2023Q4

1964

171.90M

85.06%

+6.01M

2023Q3

1864

166.03M

82.05%

+4.34M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

22.40M

11.55%

+1.12M

+5.26%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

12.03M

6.21%

+1.02M

+9.29%

Jun 30, 2025

State Street Investment Management (US)

8.41M

4.34%

-6.73K

-0.08%

Jun 30, 2025

Walgreens Boots Alliance Inc

7.47M

3.85%

-2.91M

-28.01%

Jun 30, 2025

T. Rowe Price Associates, Inc.

7.46M

3.85%

-1.87M

-20.05%

Jun 30, 2025

Geode Capital Management, L.L.C.

4.79M

2.47%

+284.23K

+6.31%

Jun 30, 2025

Boston Partners

4.42M

2.28%

-991.53K

-18.32%

Jun 30, 2025

Wellington Management Company, LLP

3.86M

1.99%

-1.57M

-28.88%

Jun 30, 2025

JP Morgan Asset Management

2.76M

1.43%

-110.19K

-3.83%

Jun 30, 2025

Fidelity Management & Research Company LLC

2.78M

1.44%

+751.58K

+36.98%

Jun 30, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

VanEck Pharmaceutical ETF

8.42%

AdvisorShares Focused Equity ETF

5.56%

First Trust Consumer Staples Alphadex Fund

3.52%

Goldman Sachs Future Health Care Equity ETF

3.48%

VanEck Retail ETF

3.31%

Hennessy Sustainable ETF

3.08%

iShares US Consumer Staples ETF

3.02%

American Century Mid Cap Growth Impact ETF

2.66%

SEI Enhanced US Large Cap Momentum Factor ETF

2.51%

Counterpoint Quantitative Equity ETF

2.4%

VanEck Pharmaceutical ETF

Proporción8.42%

AdvisorShares Focused Equity ETF

Proporción5.56%

First Trust Consumer Staples Alphadex Fund

Proporción3.52%

Goldman Sachs Future Health Care Equity ETF

Proporción3.48%

VanEck Retail ETF

Proporción3.31%

Hennessy Sustainable ETF

Proporción3.08%

iShares US Consumer Staples ETF

Proporción3.02%

American Century Mid Cap Growth Impact ETF

Proporción2.66%

SEI Enhanced US Large Cap Momentum Factor ETF

Proporción2.51%

Counterpoint Quantitative Equity ETF

Proporción2.4%

Dividendos



Un total de 2.01B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Nov 04, 2025

COR.NB Final Cash Dividend of gross USD 0.6 paid on Dec 01, 2025 going ex on Nov 14, 2025

Nov 14, 2025

Dec 01, 2025

Nov 14, 2025

Aug 06, 2025

COR.NB Interim Cash Dividend of gross USD 0.55 paid on Sep 03, 2025 going ex on Aug 15, 2025

Aug 15, 2025

Sep 03, 2025

Aug 15, 2025

May 07, 2025

COR.NB Interim Cash Dividend of gross USD 0.55 paid on Jun 02, 2025 going ex on May 16, 2025

May 16, 2025

Jun 02, 2025

May 16, 2025

Feb 05, 2025

COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Mar 03, 2025

Feb 14, 2025

Nov 06, 2024

COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024

Nov 15, 2024

Nov 29, 2024

Nov 15, 2024

Jul 31, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024

Aug 09, 2024

Aug 26, 2024

Aug 09, 2024

May 01, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024

May 10, 2024

May 24, 2024

May 09, 2024

Jan 31, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024

Feb 09, 2024

Feb 26, 2024

Feb 08, 2024

Nov 02, 2023

COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023

Nov 13, 2023

Nov 27, 2023

Nov 10, 2023

Aug 02, 2023

COR.NB Interim Cash Dividend of gross USD 0.485 paid on Aug 28, 2023 going ex on Aug 10, 2023

Aug 11, 2023

Aug 28, 2023

Aug 10, 2023

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Cencora Inc?



Los cinco principales accionistas de Cencora Inc son:
The Vanguard Group, Inc. posee 22.40M acciones, lo que representa el 11.55% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 12.03M acciones, lo que representa el 6.21% del total de acciones.
State Street Investment Management (US) posee 8.41M acciones, lo que representa el 4.34% del total de acciones.
Walgreens Boots Alliance Inc posee 7.47M acciones, lo que representa el 3.85% del total de acciones.
T. Rowe Price Associates, Inc. posee 7.46M acciones, lo que representa el 3.85% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Cencora Inc?



Los tres principales tipos de accionista de Cencora Inc son:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

¿Cuántas instituciones poseen acciones de Cencora Inc (COR)?



A fecha de 2025Q4, 2325 instituciones poseen acciones de Cencora Inc, con un valor de mercado combinado de aproximadamente 185.17M, lo que representa el 94.90% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -0.19%.

¿Cuál es la mayor fuente de ganancias de Cencora Inc?



El --, el segmento empresarial -- generó la ganancia más alta para Cencora Inc, ascendiendo a -- y representando el --% de la ganancia total.

KeyAI

